Seasonal influenza vaccine in immunocompromised persons

References

• WHO. Influenza (Seasonal) 2016 [updated November 2016]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
   Google Scholar
• Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002;2(3):287–91. doi:10.1034/j.1600-6143.2002.20315.x. PMID:12096793.
   PubMed Web of Science ®Google Scholar
• Sellers SA, Hagan RS, Hayden FG, Fischer WA, 2nd. The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses. 2017;11(5):372–93. doi:10.1111/irv.12470. PMID:28745014.
   PubMed Web of Science ®Google Scholar
• Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010;10(8):521–6. doi:10.1016/S1473-3099(10)70133-X. PMID:20620116.
   PubMed Web of Science ®Google Scholar
• Beck CR, McKenzie BC, Hashim AB, Harris RC, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis. 2012;206(8):1250–9. doi:10.1093/infdis/jis487. PMID:22904335.
   PubMed Web of Science ®Google Scholar
• (NACI) AACSA-NACoI. Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2017–2018: Public Health Agency of Canada May 2017 [Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2017-2018.html.
   Google Scholar
• Control. ECfDPa. Seasonal influenza vaccination in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. Stockholm: ECDC; 2017; [Available from: https://ecdc.europa.eu/en/publications-data/seasonal-influenza-vaccination-europe.
   Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44. doi:10.1016/S1473-3099(11)70295-X. PMID:22032844.
   PubMed Web of Science ®Google Scholar
• McKee AS, Munks MW, Marrack P. How do adjuvants work? Important considerations for new generation adjuvants. Immunity. 2007;27(5):687–90. doi:10.1016/j.immuni.2007.11.003. PMID:18031690.
   PubMed Web of Science ®Google Scholar
• Tritto E, Mosca F, De Gregorio E. Mechanism of action of licensed vaccine adjuvants. Vaccine. 2009;27(25–26):3331–4. doi:10.1016/j.vaccine.2009.01.084. PMID:19200813.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Kool M, Willart MA, Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol. 2009;21(1):23–9. doi:10.1016/j.coi.2009.01.004. PMID:19246182.
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Noh JY, Seo YB, Choi WS, Cho GJ, Hwang TG, Kim WJ. Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine. J Med Virol. 2013;85(9):1591–7. doi:10.1002/jmv.23630. PMID:23852684.
   PubMed Web of Science ®Google Scholar
• Noh JY, Song JY, Choi WS, Lee J, Seo YB, Kwon YJ, Ko GJ, Cha DR, Kang YS, Lee YK, et al. Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines. Hum Vaccin Immunother. 2016;12(11):2902–8. doi:10.1080/21645515.2016.1191717. PMID:27802078.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J. 2009;28(7):563–71. doi:10.1097/INF.0b013e31819d6394. PMID:19561422.
   PubMed Web of Science ®Google Scholar
• Block SL, Ruiz-Palacios GM, Guerrero ML, Beygo J, Sales V, Holmes SJ. Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. Pediatr Infect Dis J. 2012;31(7):e92–8. doi:10.1097/INF.0b013e318257644f. PMID:22481427.
   PubMed Web of Science ®Google Scholar
• Caspard H, Mallory RM, Yu J, Ambrose CS. Live-attenuated influenza vaccine effectiveness in children from 2009 to 2015–2016: a systematic review and meta-analysis. Open Forum Infect Dis. 2017;4(3):ofx111. doi:10.1093/ofid/ofx111. PMID:28852675.
   PubMed Web of Science ®Google Scholar
• Baz M, Luke CJ, Cheng X, Jin H, Subbarao K. H5N1 vaccines in humans. Virus Res. 2013;178(1):78–98. doi:10.1016/j.virusres.2013.05.006. PMID:23726847.
   PubMed Web of Science ®Google Scholar
• Furuya Y. Return of inactivated whole-virus vaccine for superior efficacy. Immunol Cell Biol. 2012;90(6):571–8. doi:10.1038/icb.2011.70. PMID:21844883.
   PubMed Web of Science ®Google Scholar
• Loubet P, Kerneis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine. 2015;33(31):3703–8. doi:10.1016/j.vaccine.2015.06.012. PMID:26073016.
   PubMed Web of Science ®Google Scholar
• Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, Chapman LE. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995–2005. Vaccine. 2009;27(17):2335–41. doi:10.1016/j.vaccine.2009.02.026. PMID:19428848.
   PubMed Web of Science ®Google Scholar
• Loubet P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O. Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: results from a web-based study. Dig Liver Dis. 2018. pii: S1590-8658(17)31364-6. doi:10.1016/j.dld.2017.12.027. PMID:29371056
   PubMedGoogle Scholar
• Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70(4):767–77. doi:10.1017/S0022172400022610. PMID:4509641.
   PubMedGoogle Scholar
• de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel). 2003;115:63–73. PMID:15088777.
   PubMedGoogle Scholar
• Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, Tsai T, Clemens R, Rappuoli R. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30(12):1081–5. doi:10.1097/INF.0b013e3182367662. PMID:21983214.
   PubMed Web of Science ®Google Scholar
• Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res. 2012;2(4):203–18. PMID:23226621.
   PubMedGoogle Scholar
• Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring index. Biol Blood Marrow Transplant. 2016;22(3):542–8. doi:10.1016/j.bbmt.2015.11.015. PMID:26638804.
   PubMed Web of Science ®Google Scholar
• Khanna N, Steffen I, Studt JD, Schreiber A, Lehmann T, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch HH. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11(2):100–5. doi:10.1111/j.1399-3062.2008.00362.x. PMID:19175540.
   PubMed Web of Science ®Google Scholar
• Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis. 2014;58(2):214–24. doi:10.1093/cid/cit725. PMID:24186906.
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18. doi:10.1093/cid/cit816. PMID:24421306.
   PubMed Web of Science ®Google Scholar
• Machado CM, Cardoso MR, da Rocha IF, Boas LS, Dulley FL, Pannuti CS. The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant. 2005;36(10):897–900. doi:10.1038/sj.bmt.1705159. PMID:16170332.
   PubMed Web of Science ®Google Scholar
• Karras NA, Weeres M, Sessions W, Xu X, Defor T, Young JA, Stefanski H, Brunstein C, Cooley S, Miller JS, et al. A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation. Biol Blood Marrow Transplant. 2013;19(1):109–16. doi:10.1016/j.bbmt.2012.08.015. PMID:22940056.
   PubMed Web of Science ®Google Scholar
• Mohty B, Bel M, Vukicevic M, Nagy M, Levrat E, Meier S, Grillet S, Combescure C, Kaiser L, Chalandon Y, et al. Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica. 2011;96(6):896–904. doi:10.3324/haematol.2011.040386. PMID:21422117.
   PubMed Web of Science ®Google Scholar
• Fukatsu Y, Nagata Y, Adachi M, Yagyu T, Ono T. Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2017;105(5):638–45. doi:10.1007/s12185-016-2163-3. PMID:27943117.
   PubMed Web of Science ®Google Scholar
• Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, Strauss N, Parag G, Naparstek E, Ravid Z, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant. 1993;11(1):1–5. PMID:8431706.
   PubMed Web of Science ®Google Scholar
• Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis. 2013;15(3):219–32. doi:10.1111/tid.12054. PMID:23363310.
   PubMed Web of Science ®Google Scholar
• Ambati A, Boas LS, Ljungman P, Testa L, de Oliveira JF, Aoun M, Colturato V, Maeurer M, Machado CM. Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study. Bone Marrow Transplant. 2015;50(6):858–64. doi:10.1038/bmt.2015.47. PMID:25798680.
   PubMed Web of Science ®Google Scholar
• Halasa NB, Savani BN, Asokan I, Kassim A, Simons R, Summers C, Bourgeois J, Clifton C, Vaughan LA, Lucid C, et al. Randomized double-blind study of the safety and immunogenicity of standard-dose trivalent inactivated influenza vaccine versus high-dose trivalent inactivated influenza vaccine in adult hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant. 2016;22(3):528–35. doi:10.1016/j.bbmt.2015.12.003. PMID:26705931.
   PubMed Web of Science ®Google Scholar
• Natori Y, Humar A, Lipton J, Kim DD, Ashton P, Hoschler K, Kumar D. A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2017;52(7):1016–21. doi:10.1038/bmt.2017.24. PMID:28263288.
   PubMed Web of Science ®Google Scholar
• Ambati A, Einarsdottir S, Magalhaes I, Poiret T, Bodenstein R, LeBlanc K, Brune M, Maeurer M, Ljungman P. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2015;17(3):371–9. doi:10.1111/tid.12382. PMID:25817044.
   PubMed Web of Science ®Google Scholar
• Danziger-Isakov L, Kumar D, Practice ASTIDCo. Vaccination in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):311–7. doi:10.1111/ajt.12122. PMID:23465023.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155.
   PubMedGoogle Scholar
• Perez-Romero P, Aydillo TA, Perez-Ordonez A, Munoz P, Moreno A, Lopez-Medrano F, Bodro M, Montejo M, Gavaldà J, Fariñas MC, et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect. 2012;18(12):E533–40. doi:10.1111/1469-0691.12044. PMID:23078072.
   PubMed Web of Science ®Google Scholar
• Kumar D, Cordero E, Blumberg E, Limaye A, Levi M, Danziger-Isakov L, Englund J, Husain S, Silveira F, Reid G, Sharma T, Humar. A 5-Year Multicenter Evaluation of Seasonal Influenza Infection in Transplant Recipients. 2016 American Transplant Congress: Am J Transplant; 2016.
   Google Scholar
• Manuel O, Humar A, Chen MH, Chernenko S, Singer LG, Cobos I, Kumar D. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant. 2007;7(11):2567–72. doi:10.1111/j.1600-6143.2007.01982.x. PMID:17908277.
   PubMed Web of Science ®Google Scholar
• Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J. 2001;18(6):971–6. doi:10.1183/09031936.01.00215201. PMID:11829104.
   PubMed Web of Science ®Google Scholar
• Baluch A, Humar A, Eurich D, Egli A, Liacini A, Hoschler K, Campbell P, Berka N, Urschel S, Wilson L, Kumar D. Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant. 2013;13(4):1026–33. doi:10.1111/ajt.12149. PMID:23406320.
   PubMed Web of Science ®Google Scholar
• Scharpe J, Evenepoel P, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Peetermans WE. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant. 2008;8(2):332–7. doi:10.1111/j.1600-6143.2007.02066.x. PMID:18162092.
   PubMed Web of Science ®Google Scholar
• Cordero E, Perez-Ordonez A, Aydillo TA, Torre-Cisneros J, Gavalda J, Lara R, Segura C, Len O, Cabral E, Gasch A, et al. Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients. Am J Transplant. 2011;11(10):2205–13. doi:10.1111/j.1600-6143.2011.03692.x. PMID:21831151.
   PubMed Web of Science ®Google Scholar
• Fairhead T, Hendren E, Tinckam K, Rose C, Sherlock CH, Shi L, Crowcroft NS, Gubbay JB, Landsberg D, Knoll G, et al. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. Transpl Infect Dis. 2012;14(6):575–83. doi:10.1111/tid.12006. PMID:22999005.
   PubMed Web of Science ®Google Scholar
• Siegrist CA, Ambrosioni J, Bel M, Combescure C, Hadaya K, Martin PY, Soccal PM, Berney T, Noble S, Meier S, et al. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther. 2012;17(5):893–903. doi:10.3851/IMP2103. PMID:22544169.
   PubMed Web of Science ®Google Scholar
• Karbasi-Afshar R, Izadi M, Fazel M, Khedmat H. Response of transplant recipients to influenza vaccination based on type of immunosuppression: a meta-analysis. Saudi J Kidney Dis Transpl. 2015;26(5):877–83. doi:10.4103/1319-2442.164556. PMID:26354557.
   PubMed Web of Science ®Google Scholar
• Orcurto A, Pascual M, Hoschler K, Aubert V, Meylan P, Manuel O. Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients. Transplantation. 2012;94(6):630–6. doi:10.1097/TP.0b013e31825f7f82. PMID:22895612.
   PubMed Web of Science ®Google Scholar
• Hequet D, Pascual M, Lartey S, Pathirana RD, Bredholt G, Hoschler K, Hullin R, Meylan P, Cox RJ, Manuel O. Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. Vaccine. 2016;34(31):3576–83. doi:10.1016/j.vaccine.2016.05.021. PMID:27219339.
   PubMed Web of Science ®Google Scholar
• Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C, Martin PY, Siegrist CA, Villard J. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant. 2011;11(8):1727–33. doi:10.1111/j.1600-6143.2011.03604.x. PMID:21672157.
   PubMed Web of Science ®Google Scholar
• Schaffer SA, Husain S, Delgado DH, Kavanaugh L, Ross HJ. Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant. 2011;11(12):2751–4. doi:10.1111/j.1600-6143.2011.03743.x. PMID:21906258.
   PubMed Web of Science ®Google Scholar
• Dos Santos G, Seifert HA, Bauchau V, Shinde V, Barbeau DM, Cohet C. Adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccines and solid organ transplant rejection: systematic signal evaluation and lessons learnt. Drug Saf. 2017;40(8):693–702. doi:10.1007/s40264-017-0532-3. PMID:28417321.
   PubMed Web of Science ®Google Scholar
• Cohet C, Haguinet F, Dos Santos G, Webb D, Logie J, Lc Ferreira G, Rosillon D, Shinde V. Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series. BMJ Open. 2016;6(1):e009264. doi:10.1136/bmjopen-2015-009264. PMID:26823177.
   PubMed Web of Science ®Google Scholar
• Kumar D, Blumberg EA, Danziger-Isakov L, Kotton CN, Halasa NB, Ison MG, Avery RK, Green M, Allen UD, Edwards KM, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant. 2011;11(10):2020–30. doi:10.1111/j.1600-6143.2011.03753.x. PMID:21957936.
   PubMed Web of Science ®Google Scholar
• Kumar D, Campbell P, Hoschler K, Hidalgo L, Al-Dabbagh M, Wilson L, Humar A. Randomized controlled trial of adjuvanted versus nonadjuvanted influenza vaccine in Kidney Transplant Recipients. Transplantation. 2016;100(3):662–9. doi:10.1097/TP.0000000000000861. PMID:26335915.
   PubMed Web of Science ®Google Scholar
• Dos Santos G, Haguinet F, Cohet C, Webb D, Logie J, Ferreira GL, Rosillon D, Shinde V. Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: a self-controlled case-series. Vaccine. 2016;34(31):3598–606. doi:10.1016/j.vaccine.2016.05.016. PMID:27216760.
   PubMed Web of Science ®Google Scholar
• Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, Schiano TD. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant. 2004;4(11):1805–9. doi:10.1111/j.1600-6143.2004.00564.x. PMID:15476480.
   PubMed Web of Science ®Google Scholar
• Birdwell KA, Ikizler MR, Sannella EC, Wang L, Byrne DW, Ikizler TA, Wright PF. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis. 2009;54(1):112–21. doi:10.1053/j.ajkd.2008.09.023. PMID:19185404.
   PubMed Web of Science ®Google Scholar
• Perez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavalda J, Aydillo TA, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, et al. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe. Clin Microbiol Infect. 2015;21(11):1040 e11-8. doi:10.1016/j.cmi.2015.07.014. PMID:26232537.
   PubMed Web of Science ®Google Scholar
• Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavalda J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Muñoz P, et al. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1–2, a Randomized Controlled Clinical Trial. Clin Infect Dis. 2017;64(7):829–38. doi:10.1093/cid/ciw855. PMID:28362949.
   PubMed Web of Science ®Google Scholar
• Le Corre N, Thibault F, Pouteil Noble C, Meiffredy V, Daoud S, Cahen R, Charreau I, Bottigioli D, Dollinger C, Aboulker JP, et al. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. Vaccine. 2012;30(52):7522–8. doi:10.1016/j.vaccine.2012.10.047. PMID:23103195.
   PubMed Web of Science ®Google Scholar
• Hojsak I, Avitzur Y, Mor E, Shamir R, Haimi-Cohen Y, Zakay-Rones Z, Wolf D, Shapiro R. Antibody response to influenza vaccine in pediatric liver transplant recipients. Pediatr Infect Dis J. 2011;30(6):491–4. doi:10.1097/INF.0b013e31820b7c22. PMID:21248658.
   PubMed Web of Science ®Google Scholar
• Liao Z, Xu X, Liang Y, Xiong Y, Chen R, Ni J. Effect of a booster dose of influenza vaccine in patients with hemodialysis, peritoneal dialysis and renal transplant recipients: A systematic literature review and meta-analysis. Hum Vaccin Immunother. 2016;12(11):2909–15. doi:10.1080/21645515.2016.1201623. PMID:27392026.
   PubMed Web of Science ®Google Scholar
• GiaQuinta S, Michaels MG, McCullers JA, Wang L, Fonnesbeck C, O'Shea A, Green M, Halasa NB. Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients. Pediatr Transplant. 2015;19(2):219–28. doi:10.1111/petr.12419. PMID:25523718.
   PubMed Web of Science ®Google Scholar
• Natori Y, Shiotsuka M, Slomovic J, Hoschler K, Ferreira V, Ashton P, Rotstein C, Lilly L, Schiff J, Singer L, et al. A double blind randomized trial of high dose vs. standard dose influenza vaccine in adult solid organ transplant recipients. Clin Infect Dis. 2017. doi:10.1093/cid/cix1082.
   Web of Science ®Google Scholar
• Magnani G, Falchetti E, Pollini G, Reggiani LB, Grigioni F, Coccolo F, Potena L, Magelli C, Sambri V, Branzi A. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant. 2005;24(5):588–92. doi:10.1016/j.healun.2004.03.004. PMID:15896757.
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant. 2011;30(6):679–84. doi:10.1016/j.healun.2011.01.705. PMID:21377898.
   PubMed Web of Science ®Google Scholar
• Yousuf HM, Englund J, Couch R, Rolston K, Luna M, Goodrich J, Lewis V, Mirza NQ, Andreeff M, Koller C, et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis. 1997;24(6):1095–9. doi:10.1086/513648. PMID:9195063.
   PubMed Web of Science ®Google Scholar
• Schepetiuk S, Papanaoum K, Qiao M. Spread of influenza A virus infection in hospitalised patients with cancer. Aust N Z J Med. 1998;28(4):475–6. doi:10.1111/j.1445-5994.1998.tb02089.x. PMID:9777122.
   PubMedGoogle Scholar
• Elting LS, Whimbey E, Lo W, Couch R, Andreeff M, Bodey GP. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer. 1995;3(3):198–202. doi:10.1007/BF00368891. PMID:7655781.
   PubMed Web of Science ®Google Scholar
• Vinograd I, Eliakim-Raz N, Farbman L, Baslo R, Taha A, Sakhnini A, Lador A, Stemmer SM, Gafter-Gvili A, Leibovici L, et al. Clinical effectiveness of seasonal influenza vaccine among adult cancer patients. Cancer. 2013;119(22):4028–35. doi:10.1002/cncr.28351. PMID:24105033.
   PubMed Web of Science ®Google Scholar
• Vinograd I, Baslo R, Eliakim-Raz N, Farbman L, Taha A, Sakhnini A, Lador A, Stemmer SM, Gafter-Gvili A, Fraser D, et al. Factors associated with influenza vaccination among adult cancer patients: a case-control study. Clin Microbiol Infect. 2014;20(9):899–905. doi:10.1111/1469-0691.12625. PMID:24655107.
   PubMed Web of Science ®Google Scholar
• Bitterman R, Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev. 2018;2:CD008983. doi:10.1002/14651858.CD008983.pub3
   PubMed Web of Science ®Google Scholar
• Nakashima K, Aoshima M, Ohfuji S, Suzuki K, Katsurada M, Katsurada N, Misawa M, Otsuka Y, Kondo K, Hirota Y. Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy. Hum Vaccin Immunother. 2017;13(3):543–50. doi:10.1080/21645515.2016.1246094. PMID:27820665.
   PubMed Web of Science ®Google Scholar
• Choi DK, Fuleihan RL, Walterhouse DO. Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer. Pediatr Blood Cancer. 2016;63(11):2011–8. doi:10.1002/pbc.26110. PMID:27327360.
   PubMed Web of Science ®Google Scholar
• Keam B, Kim MK, Choi Y, Choi SJ, Choe PG, Lee KH, Kim TM, Kim TY, Oh DY, Kim DW, et al. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles. Cancer. 2017;123(5):841–8. doi:10.1002/cncr.30468. PMID:27997703.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol. 2005;130(1):96–8. doi:10.1111/j.1365-2141.2005.05582.x. PMID:15982350.
   PubMed Web of Science ®Google Scholar
• Sanada Y, Yakushijin K, Nomura T, Chayahara N, Toyoda M, Minami Y, Kiyota N, Mukohara T, Kawamoto S, Ito M, et al. A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy. Jpn J Clin Oncol. 2016;46(5):448–52. doi:10.1093/jjco/hyw020. PMID:26977053.
   PubMed Web of Science ®Google Scholar
• Jamshed S, Walsh EE, Dimitroff LJ, Santelli JS, Falsey AR. Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: a pilot randomized clinical trial. Vaccine. 2016;34(5):630–5. doi:10.1016/j.vaccine.2015.12.037. PMID:26721330.
   PubMed Web of Science ®Google Scholar
• Hakim H, Allison KJ, Van de Velde LA, Tang L, Sun Y, Flynn PM, McCullers JA. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection. Vaccine. 2016;34(27):3141–8. doi:10.1016/j.vaccine.2016.04.053. PMID:27129426.
   PubMed Web of Science ®Google Scholar
• McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(5):815–20. doi:10.1002/pbc.24863. PMID:24249544.
   PubMed Web of Science ®Google Scholar
• Brocq O, Acquacalda E, Berthier F, Albert C, Bolla G, Millasseau E, Destombe C, Azulay J, Asquier C, Florent A, et al. Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: a retrospective study. Joint Bone Spine. 2016;83(2):155–9. doi:10.1016/j.jbspin.2015.11.005. PMID:26725745.
   PubMed Web of Science ®Google Scholar
• Chang CC, Chang YS, Chen WS, Chen YH, Chen JH. Effects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: a Nationwide Cohort Study. Sci Rep. 2016;6:37817. doi:10.1038/srep37817. PMID:27910867.
   PubMed Web of Science ®Google Scholar
• Puges M, Biscay P, Barnetche T, Truchetet ME, Richez C, Seneschal J, Gensous N, Lazaro E, Duffau P. Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis. Rheumatology (Oxford). 2016;55(9):1664–72. doi:10.1093/rheumatology/kew211. PMID:27160278.
   PubMed Web of Science ®Google Scholar
• Liao Z, Tang H, Xu X, Liang Y, Xiong Y, Ni J. Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: a meta-analysis. PLoS One. 2016;11(2):e0147856. doi:10.1371/journal.pone.0147856. PMID:26845680.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang H, Tam WWS. Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis. Curr Med Res Opin. 2017;33(10):1901–8. doi:10.1080/03007995.2017.1329140. PMID:28489423.
   PubMed Web of Science ®Google Scholar
• deBruyn J, Fonseca K, Ghosh S, Panaccione R, Gasia MF, Ueno A, Kaplan GG, Seow CH, Wrobel I. Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial. Inflamm Bowel Dis. 2016;22(3):638–47. doi:10.1097/MIB.0000000000000615. PMID:26595551.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, et al. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial. J Gastroenterol. 2015;50(8):876–86. doi:10.1007/s00535-015-1042-7. PMID:25672513.
   PubMed Web of Science ®Google Scholar
• Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients. Clin Exp Immunol. 2014;178(1):40–7. doi:10.1111/cei.12390. PMID:24889761.
   PubMed Web of Science ®Google Scholar
• Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine. 2011;29(8):1643–8. doi:10.1016/j.vaccine.2010.12.072. PMID:21211590.
   PubMed Web of Science ®Google Scholar
• van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum. 2010;62(1):75–81. doi:10.1002/art.25033. PMID:20039396.
   PubMed Web of Science ®Google Scholar
• Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, et al. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis. 2008;67(7):937–41. doi:10.1136/ard.2007.077461. PMID:17981914.
   PubMed Web of Science ®Google Scholar
• Podczervinski S, Stednick Z, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches. Am J Infect Control. 2015;43(3):228–33. doi:10.1016/j.ajic.2014.11.025. PMID:25728148.
   PubMed Web of Science ®Google Scholar
• Frenzel E, Chemaly RF, Ariza-Heredia E, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control. 2016;44(9):1016–21. doi:10.1016/j.ajic.2016.03.024. PMID:27158088.
   PubMed Web of Science ®Google Scholar